Pages that link to "Item:Q3079157"
From MaRDI portal
The following pages link to Bayesian Optimal Designs for Phase I Clinical Trials (Q3079157):
Displayed 24 items.
- Information in a two-stage adaptive optimal design (Q389442) (← links)
- Adaptive Bayesian compound designs for dose finding studies (Q434557) (← links)
- Incorporating a patient dichotomous characteristic in cancer phase I clinical trials using escalation with overdose control (Q454783) (← links)
- Stochastic approximation and modern model-based designs for dose-finding clinical trials (Q903289) (← links)
- Bayesian models and decision algorithms for complex early phase clinical trials (Q903294) (← links)
- Approximate dynamic programming and its applications to the design of Phase I cancer trials (Q903295) (← links)
- Convergence properties of sequential Bayesian \(D\)-optimal designs (Q958799) (← links)
- Penalized optimal designs for dose-finding (Q1036729) (← links)
- Optimal sequential designs in phase I studies (Q1621308) (← links)
- Escalation with overdose control using ordinal toxicity grades for cancer phase I clinical trials (Q1929691) (← links)
- Random norming AIDS analysis of non-linear regression models with sequential informative dose selection (Q2301071) (← links)
- On optimal designs for clinical trials: an updated review (Q2301225) (← links)
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- Compound optimal designs for percentile estimation in dose-response models with restricted design intervals (Q2455406) (← links)
- Adaptive designs for selecting drug combinations based on efficacy-toxicity response (Q2475724) (← links)
- Adaptive designs for dose-finding based on efficacy-toxicity response (Q2492921) (← links)
- Sequential Two-stage D-optimality Sensitivity Test for Binary Response Data (Q2943798) (← links)
- A Bayesian adaptive dose-finding algorithm for balancing individual- and population-level ethics in Phase I clinical trials (Q2958397) (← links)
- The augmentation of existing data for improving the path of steepest ascent (Q2979010) (← links)
- Incorporating Individual and Collective Ethics into Phase I Cancer Trial Designs (Q3013989) (← links)
- Sequential Methods in Multi-Arm Clinical Trials (Q3068083) (← links)
- A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents (Q3183236) (← links)
- Adaptive Design Optimization: A Mutual Information-Based Approach to Model Discrimination in Cognitive Science (Q3556782) (← links)
- A Semiparametric Sequential Algorithm for Estimation of Dose–Response Curve (Q4924128) (← links)
